Clinical Topics & News
Cervical Cancer Screening
In Europe, the most commonly recommended interval for cervical cancer screening is three years. But that interval can safely be extended to six years for women who test negative for human papillomavirus (HPV), according to the findings of a multinational cohort study with joint database analysis.
Clinical Topics
-
Study of beliefs about what causes cancer sparks debate -
Tips on Better Patients Communication -
VA Center Dramatically Shrinks Wait Times for Bone Marrow Biopsies -
In VA Oncology, Discussion Groups Are Transforming the Workplace -
Burnout Is Rampant, But Oncologists Can Turn the Tide
Digital Edition
Multimedia
Conference Coverage
-
Registered Dieticians Sparse in VA Cancer Care -
-
Which Medication Is Best? VA Genetic Tests May Have the Answer -
IMRT vs Proton Therapy for Early Prostate Cancer? -
Head and Neck Cancer: Should Patients Get PEG Access Prior to Therapy? VA pilot study could help clinicians make better-informed decisions to head off malnutrition -
Transgender Women and Prostate Cancer: It’s Complicated -
Changes in Age-Related Mortality in Malignant Melanoma From 1999- 2022: A CDC Wonder Study -
Geographical Trends in Malignant Melanoma from 1999-2022: A CDC Wonder Study -
Implementation of an Intervention to Improve Efficiency and Accuracy of Data Entry into the Veterans Affairs Central Cancer Registry at the Lexington VA Healthcare System -
A Phase II Study With Androgen Deprivation Therapy and Up-Front Radiotherapy in High-Intermediate and High-Risk Prostate Cancer With Stereotactic Body Radiation Therapy to Pelvic Nodes and Concomitant Prostate Boost by Simultaneous Integrated Boost
Question 1 of 5
